Codes / ICD10CM / H34.8131

H34.8131 Central retinal vein occlusion, bilateral, with retinal neovascularization

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Central Retinal Vein Occlusion, Bilateral, with Retinal Neovascularization (ICD-10: H34.8131)

Summary

Central retinal vein occlusion (CRVO) occurs when the main vein draining blood from the retina becomes blocked, disrupting blood flow and potentially leading to vision problems or loss. In this case, both eyes are affected, and retinal neovascularization is present, which may result in sudden or gradual visual impairment depending on the severity of the occlusion. The condition typically impacts both eyes and can cause symptoms ranging from mild blurring to severe vision loss due to abnormal blood vessel growth in the retina.

Causes

CRVO is often caused by a blood clot in the central retinal vein. Underlying factors such as atherosclerosis, inflammation, or compression of the vein may contribute to the blockage. Systemic conditions like hypertension or hypercoagulability can also play a role in the development of the occlusion.

Risk Factors

  • Advanced age
  • High blood pressure
  • Diabetes mellitus
  • Glaucoma
  • High cholesterol
  • Smoking
  • Cardiovascular disease
  • Blood disorders (e.g., hypercoagulability)

Symptoms

  • Sudden, painless vision loss in both eyes
  • Blurred or distorted vision
  • Floaters or dark spots in the visual field
  • Peripheral vision loss
  • Abnormal blood vessel growth in the retina (neovascularization)

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, dilated funduscopy, and imaging studies such as fluorescein angiography or optical coherence tomography (OCT) to assess retinal blood flow and structure. Additional tests may evaluate underlying systemic conditions and confirm the presence of neovascularization.

Treatment Options

Treatment focuses on managing the underlying cause, reducing complications, and preserving vision. Options may include anti-VEGF injections, laser photocoagulation, or corticosteroids to address neovascularization and macular edema. Systemic treatments for associated conditions like hypertension or diabetes may also be necessary.

Prognosis and Follow-Up

Prognosis varies depending on the severity of the occlusion and the presence of complications. Regular follow-up with an ophthalmologist is essential to monitor for neovascularization, macular edema, or other issues. Early intervention can help preserve vision and prevent further damage.

Complications

  • Retinal neovascularization (abnormal blood vessel growth)
  • Macular edema (fluid accumulation in the macula)
  • Vitreous hemorrhage
  • Neovascular glaucoma
  • Permanent vision loss

Lifestyle & Prevention

  • Manage blood pressure and cholesterol levels
  • Control diabetes through diet and medication
  • Avoid smoking
  • Maintain a healthy weight
  • Regular eye examinations, especially for those with risk factors

When to Seek Professional Help

Seek immediate medical attention if you experience sudden, painless vision loss in one or both eyes, blurred vision, or floaters. Prompt evaluation is critical to prevent complications and preserve vision.

Tips for Medical Coders

Document the bilateral nature of the occlusion and the presence of retinal neovascularization clearly in the medical record. Ensure the diagnosis is supported by clinical findings and imaging studies. The code H34.8131 specifically requires documentation of both eyes being affected and the presence of neovascularization.

Book a walkthrough

H34.8131 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.